Videos / New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).
The Natural Estrogen Debate: A Focus on Combined Oral Contraception
Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes
Eczema Management Practical Tips
Menopausal Hormone Therapy and its Cardiovascular Benefits
expert
Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland